Lacticaseibacillus rhamnosus GG is one of the most studied probiotic strains，characterized by high acid resistance，high bile salt resistance，and strong adhesion.The main functions of Lacticaseibacillus rhamnosus GG include enhancing intestinal barrier function，inhibiting pathogen adhesion，regulating the body's immune system，which make it effective in treating and preventing gastrointestinal diseases in children and adults.This article reviewes the application research progress of Lacticaseibacillus rhamnosus GG in the treatment of common pediatric digestive system diseases such as necrotizing enterocolitis，infantile colic，non-alcoholic fatty liver disease，inflammatory bowel disease，antibiotic associated diarrhea，irritable bowel syndrome，and acute gastroenteritis in children.

Bronchopulmonary dysplasia（BPD），a common chronic respiratory disease caused by multiple factors，can seriously affect the quality of life and prognosis of prematurity.A variety of factors，including infection and oxidative stress，can contribute to the development of BPD in prematurity.Interleukin 6（IL-6），as an important cytokine that activates various signal cascades and participates in many physiological processes in the body，is currently considered to be one of the independent risk factors for the development of BPD in prematurity.The IL-6-related signal pathways，represented by JAK/STAT，can play an important role in the development of BPD through various pathways such as lung injury，pulmonary angiogenesis，proliferation and apoptosis of epithelial cells，and ferroptosis.This article reviews the studies on the mechanism of IL-6-related signal pathways in BPD，which will provide possible new targets for its treatment in BPD in the future.

Autism spectrum disorder（ASD）is a multifactorial，pervasive neurodevelopmental disorder.As the morbidity rate of ASD in children increases year by year，feeding and eating behaviors，as an important and common clinical problem in children with ASD，are gaining more and more attention.Many children with ASD often have food selection issues，chewing problems，food allergy and related gastrointestinal symptoms，and even serious diseases such as eating disorders，which negatively impact on their growth and development.There are many factors affecting feeding and eating behavior problems in children with ASD，such as sensory processing，ritualistic eating behavior，gastrointestinal symptoms，age，and parenting pressure.There are also a variety of interventions that can help to improve feeding and eating behavior problems in children with ASD.Strengthening the understanding of these influencing factors and intervention treatment methods is beneficial for improving the quality of life in children with ASD.

Asthma is one of the most common chronic respiratory diseases.Inhaled corticosteroid（ICS）are the first line of asthma maintenance therapy.ICS maintenance therapy combined with short-acting beta-2 agonist（SABA）reliever therapy has been a common treatment in the past few decades.However，there are some problems such as poor patient compliance.In recent years，the Global Initiative for Asthma（GINA）has suggested that low-dose ICS-formoterol is preferred as a reliever therapy to help improve patient compliance and reduce the risk of exacerbation after an acute attack of asthma.This article summarizes the application value of ICS-formoterol in the treatment of asthma maintenance and reliever.

Children who ingest corrosive substances by mistake usually have a small amount of exploratory ingestion，so perforation caused by injury is rare，and emergency surgical treatment is rarely required in the acute stage.But it is very easy to cause esophageal stenosis in the long term.Esophageal stenosis can last for weeks to months，and the children's difficult swallowing can lead to chronic pain in the esophagus and long-term malnutrition.At present，the main clinical treatment is endoscopic esophageal dilation，which requires multiple dilation treatments.The treatment period of corrosive esophageal stenosis in children is long，if supplemented with effective drugs during treatment，it is expected to reduce the degree of esophageal stenosis，reduce the number of dilation，and shorten the treatment period.On the other hand，early administration of protective drugs can promote benign wound healing after esophageal injury.This article reviews the research progress on drug treatment for corrosive esophageal stenosis in children.

Small intestinal bacterial overgrowth（SIBO）is a clinically common but poorly recognized disease with clinical symptoms that overlap with those of functional gastrointestinal disorders（FGID）. FGID is a common risk factor for the occurrence of SIBO，and its SIBO incidence rate is significantly higher than that of healthy people，and has a certain correlation. Intestinal microbiota dysbiosis（including SIBO）plays an important role in the pathophysiology of FGID. At present，the diagnosis and treatment of SIBO still face challenges，and the treatment plan of FGID is gradually introduced into the treatment of SIBO. SIBO and FGID are closely related in clinical manifestations，incidence rate，pathophysiology，treatment and other aspects，but there is little research on the relationship between them. Prospective and large-scale clinical research is still needed to improve understanding and diagnostic accuracy.This article reviews the research progress on the relationship between SIBO and FGID.

Sepsis is a life-threatening organ dysfunction caused by dysfunctional response to infection.Its key pathogenic links include immune damage and target organ involvement，which is a major cause of death in critically ill children.O-linked N-acetylglucosamine（O-GlcNAc）glycosylation，an important post-translational modification of proteins，influences various biological processes，including glucose metabolism，immune inflammatory response，and ferroptosis，by modifying specific proteins，thereby playing a role in the onset and progression of sepsis.Research indicates that O-GlcNAcylation has an important protective effect against organ injuries in the heart，brain，lungs，liver，and intestines during sepsis.However，the impact of this modification can vary depending on the target proteins and the cellular environment.From both the domestic and international perspective，this paper reviews the advances in O-GlcNAcylation in the pathogenesis of septic organ injury，aiming to offer new insights and strategies for the clinical management of sepsis.

Infantile spasm is an age-related epileptic encephalopathy，most are drug-resistant，as the chirldren grow older，it will transfer into other epileptic syndrome.Most chirldren have a bad prognosis with neurodevelomental disorders.For now，aderenocortitropic hormone，glucocorticoid and vigabatrin are first-line treatment choice.But the control rate of spasm、remission rate of EEG and recurrence rate after first-line treatment are not ideal.It's necessary to find more effective treatment plans desperately.Considering the diversity and complexity of infantile spasm's etiologies，there are a lot of studies about treatment plan based on etiology.Controlling spasm more effectively，improving prognosis，personalized therapy and targeted therapy become the new focus.This article reviews the current treatment status of infantile spasm，also upates some novel methods which is not widely applied in clinical practice.

Very preterm infant（VPI）is a high-risk group for gut microbiota dysbiosis and neurodevelopmental disorders.There is a strong link between the gut microbiota and neurodevelopment early in life，especially for VPI，and this link has attracted increasing attention.There is a lack of insight into the mechanisms underlying the microbiota-gut-brain axis（MGBA）in VPI.By studying traumatic diseases，infectious diseases，and different gut flora，it is found that early-life intestinal microbiota abnormalities have an important impact on the host's long-term neurological development.This review focuses on the association between gut microbiota and neurological behavior during early development in VPI，and provide reference for improving neurological development and growth in VPI.

Obstructive sleep apnea syndrome（OSAS）is a common sleep disorder in children，which can cause hypoxemia and hypercapnia，leading to damage to multiple systems and organs in the body，and triggering diseases in neurocognitive function，cardiovascular，metabolic，endocrine，and other aspects.Especially，cognitive impairment is more common，manifested in six aspects：global intelligence，memory，attention，executive function，language and visuospatial ability.The rating scales are important means of collecting data in the psychological assessment of children's developmental behavior，providing important scientific basis for clinical diagnosis and disease observation.This review categorizes and summarizes cognitive function related rating scales for children with OSAS.